The Madeira Chemistry Research Center (CQM) organizes the 7th edition of Nanoschool, from 6th to 9th October 2014, with Ruth Duncan, a special guest lecturer from the Cardiff University (Professor of Cell Biology and Drug Delivery).
As in previous editions Nanoschool 2014 is promoted with two distinct initiatives: the Nanoschool Course, entitled “Nanomedicines: Considerations for Design and Transfer into Clinical Use”, for registered participants, and the Nanoschool Conference, entitled "Nanomedicines: Fact of Fiction?", open for the public in general.
NANOSCHOOL COURSE
Title: "Nanomedicines: Considerations for Design and Transfer into Clinical Use".
Dates: 6th, 7th and 9th October 2014, from 15h00-17h00; 8th October 2014, from 14h30-16h30.
Venue: room 0.57, level 0 (University of Madeira, Campus of Penteada).
Program:
LESSON #01 MONDAY, 6TH
What is nanomedicine and why do we need it? Current Status of Nanomedicines in Clinical Use and Clinical Trial: Examples of Rationale for Design. Future Opportunities?
LESSON #02 TUESDAY, 7TH
Biological Barriers, Endocytosis and Intracellular Trafficking - Key Players that Determine Nanomedicine Performance - Safety and Efficacy. What are the Future Opportunities for Improved Nanomedicine Design?
LESSON #03 WEDNESDAY, 8TH
Designing Polymer Therapeutics as Anticancer Nanomedicines: Choice of the Polymer/Nanomaterial, the Drug, the Targeting Residue (± Imaging Agent), Considerations During Translation. How can we better Select Patients Most Likely to Respond To Nanomedicine Therapy? Opportunities for Design as Treatments for Other Diseases
LESSON #04 THURSDAY, 9TH
Translation of Nanomedicines from Lab to Clinical Practice: Nanotoxicology, Nanomedicines Regulation, and Ethical Considerations (Are Nanomaterials Safe or Dangerous?)
Registration
Required, registration form available here (from 10th July to 28th September 2014).
Vacancies: 10 (minimum) up to 40 (maximum).
Fees:
- Member of the Madeira Chemistry Research Center: exempt from payment
- Member of the Madeira Chemistry Research Center attending the 1st cycle in Biochemistry, 2nd cycle of Applied Biochemistry and the 2nd cycle of Nanochemistry and Nanomaterials: exempt from payment
- Member of the Madeira Chemistry Research Center attending the 3rd cycle (PhD student): exempt from payment
- Student non-member of CQM, attending the 1st cycle of Biochemistry, 1st cycle of Medicine (UMa), 2nd cycle of Applied Biochemistry and 2nd cycle of Nanochemistry and Nanomaterials: 25.00€
- Former student of UMa (degree obtained less than 5 years ago): 40.00€
- Others: 50.00€
Notes: 1) The registration fee includes: attendance in class, participation certificate and support material in electronic format (copyright and related rights are applied). 2) Holders of the membership card of the Academic Association of UMa benefit from a 50% discount in the registration fee upon exhibition of a copy of the membership card. 3) In case of cancellation of the course for reasons attributable to the organization, the registration fee will be refunded, deducting expenses with bank charges.
Important dates:
Announcement of selected candidates: 30th September 2014 at http://cqm.uma.pt.
Payment of fees: from 30th September to 2nd October 2014 via bank wire transfer.
NANOSCHOOL CONFERENCE
Title: "Nanomedicines: Fact of Fiction?".
Date: 8th October 2014 - 17h00.
Venue: Conference room "Sala do Senado", level -2 (University of Madeira, Campus of Penteada).
Registration: not required, free access.
ABOUT THE LECTURER
Ruth Duncan (Professor of Cell Biology and Drug Delivery) is Professor Emerita, Cardiff Univ. Her research focused on the rationale design of polymer therapeutics and their transfer from lab to clinic. Six polymer anticancer conjugates and the first polymeric gamma camera imaging agents arising from this research have entered clinical development. To further this programme Ruth established the CRC Polymer Controlled Drug Delivery Group at Keele Univ. and later the Centre for Polymer Therapeutics at the London and Welsh Schools of Pharmacy. She also held the position of Head of New Technologies/Project Team Leader in Farmitalia Carlo Erba (later Pharmacia) Milan during transfer of the first synthetic polymer anticancer conjugates arising from her research into Phase I/II clinical trials. Due to her interdisciplinary background she was invited to Chair of the Steering Committee of the European Science Foundation's (ESF) Forward Look on Nanomedicine (2005), and is currently a member of the CPS EAG of the UK Medicines and Health Regulatory Agency, and European Medicines Agenecy Drafting Group on Nanomedicine. A past chair of the Gordon Research Conference on Drug Carriers in Biology and Medicine, she has been a recipient of many awards including the Pfizer Research Award for Pharmaceutical Sciences, the GSK International Achievement Award and Interdisciplinary Award of the Royal Society for Chemistry. UK. She is also a member of the Academy of Sciences and Literature, Mainz, the Spanish National Royal Academy of Pharmacy (RANF), and she is a Fellow of the Japanese Association of Pharmaceutical Technology (APSTJ) and the Academy of Pharmaceutical Sciences, UK.
